These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 20424577)

  • 1. The imbalance of cathepsin B-like activity in acromegalic patients--preliminary report.
    Daroszewski J; Bolanowski M; Kaluzny M; Siewinski M
    Neuro Endocrinol Lett; 2010; 31(2):256-60. PubMed ID: 20424577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly.
    Sartorio A; Cattaneo M; Bucciarelli P; Bottasso B; Porretti S; Epaminonda P; Faglia G; Arosio M
    Exp Clin Endocrinol Diabetes; 2000; 108(7):486-92. PubMed ID: 11083070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic growth hormone excess is associated with increased aldosterone: a study in patients with acromegaly and in growth hormone transgenic mice.
    Bielohuby M; Roemmler J; Manolopoulou J; Johnsen I; Sawitzky M; Schopohl J; Reincke M; Wolf E; Hoeflich A; Bidlingmaier M
    Exp Biol Med (Maywood); 2009 Aug; 234(8):1002-9. PubMed ID: 19491373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment.
    Colao A; Terzolo M; Bondanelli M; Galderisi M; Vitale G; Reimondo G; Ambrosio MR; Pivonello R; Lombardi G; Angeli A; degli Uberti EC
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):613-20. PubMed ID: 18410555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
    Wiesli P; Zwimpfer C; Zapf J; Schmid C
    Acta Obstet Gynecol Scand; 2006; 85(8):900-5. PubMed ID: 16862465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor binding protein-3 levels during early and late follow-up after surgery in acromegalic patients.
    Charalampaki P; Hildebrandt G; Schaeffer HJ; Schönau E; Klug N
    Exp Clin Endocrinol Diabetes; 1998; 106(2):130-4. PubMed ID: 9628244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discordant nadir GH after oral glucose and IGF-I levels on treated acromegaly: refining the biochemical markers of mild disease activity.
    Elias PC; Lugao HB; Pereira MC; Machado HR; Castro Md; Moreira AC
    Horm Metab Res; 2010 Jan; 42(1):50-5. PubMed ID: 19798623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum adiponectin levels in adult growth hormone deficiency and acromegaly.
    Fukuda I; Hizuka N; Ishikawa Y; Itoh E; Yasumoto K; Murakami Y; Sata A; Tsukada J; Kurimoto M; Okubo Y; Takano K
    Growth Horm IGF Res; 2004 Dec; 14(6):449-54. PubMed ID: 15519253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PPAR-gamma activator rosiglitazone fails to lower plasma growth hormone and insulin-like growth factor-1 levels in patients with acromegaly.
    Bastemir M; Akin F; Yaylali GF
    Neuroendocrinology; 2007; 86(2):119-23. PubMed ID: 17671378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of cognitive performance by using P300 auditory event related potentials (ERPs) in patients with growth hormone (GH) deficiency and acromegaly.
    Tanriverdi F; Yapislar H; Karaca Z; Unluhizarci K; Suer C; Kelestimur F
    Growth Horm IGF Res; 2009 Feb; 19(1):24-30. PubMed ID: 18567522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone isoforms in acromegalic patients before and after treatment with octreotide LAR.
    Lima GA; Wu Z; Silva CM; Barbosa FR; Dias JS; Schrank Y; Strasburger CJ; Gadelha MR
    Growth Horm IGF Res; 2010 Apr; 20(2):87-92. PubMed ID: 19884028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on the activity of acromegaly: evaluation of IGF-I].
    Larrañaga J; Carbó E; Horcajada C; Herrera Pombo JL
    Rev Clin Esp; 1991 Feb; 188(3):131-5. PubMed ID: 1780511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels of vascular endothelial growth factor in patients with acromegaly.
    Nagai Y; Ando H; Nohara E; Yamashita H; Takamura T; Kobayashi K
    Horm Metab Res; 2000 Aug; 32(8):326-9. PubMed ID: 10983629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The place of insulin-like growth factor I in the diagnosis of acromegaly].
    Dohán O; Góth M; Szabolcs I; Kovács L; Kovács Z; Szilágyi G
    Orv Hetil; 1993 Oct; 134(42):2301-3. PubMed ID: 8233444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of acromegaly with octreotide-LAR: extensive experience in a Brazilian institution.
    Jallad RS; Musolino NR; Salgado LR; Bronstein MD
    Clin Endocrinol (Oxf); 2005 Aug; 63(2):168-75. PubMed ID: 16060910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cathepsin B-like enzyme activity in cell lysate from cultured human normal keratinocytes.
    Ohno T; Hayashi S; Takata Y; Ueda D; Dekio S
    Hum Cell; 1998 Dec; 11(4):239-42. PubMed ID: 10363162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human nasal septal cartilage: analysis of intracellular enzyme activities, glycogen content, cell density and clonal proliferation of septal chondrocytes of healthy adults and acromegalic patients.
    Vetter U; Zapf J; Henrichs I; Gammert C; Heinze E; Pirsig W
    Connect Tissue Res; 1989; 18(4):243-54. PubMed ID: 2526004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase 2 (MMP-2) levels are increased in active acromegaly patients.
    Karci AC; Canturk Z; Tarkun I; Cetinarslan B
    Endocrine; 2017 Jul; 57(1):148-155. PubMed ID: 28332074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of cathepsin B-like enzyme activity and cysteine proteinase inhibitor in melanocytic tumours.
    Yoshii A; Kageshita T; Tsushima H; Ono T
    Arch Dermatol Res; 1995; 287(2):209-13. PubMed ID: 7763093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of cathepsin B activity in human breast cancer tissue by cysteine peptidase inhibitor isolated from human placenta: immunohistochemical and biochemical studies.
    Saleh Y; Siewiński M; Sebzda T; Jeleń M; Ziółkowski P; Gutowicz J; Gryboś M; Pawelec M
    Folia Histochem Cytobiol; 2003; 41(3):161-7. PubMed ID: 13678335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.